FDA product code LSE: Epstein-Barr Virus, Other
LSE is the FDA product code for epstein-barr virus, other. It is a Class I device, regulated under 21 CFR 866.3235 and reviewed by the Microbiology panel. FDA has cleared 58 510(k) submissions under LSE, 3 in the last five years, from 26 different applicants. The average 510(k) review took 176 days (median 146); 260 days on average over the last three years. FDA has posted 7 recalls for LSE devices, 1 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Epstein-Barr Virus, Other |
| Device class | Class I |
| Regulation | 21 CFR 866.3235 |
| Review panel | MI — Microbiology |
| Medical specialty | Microbiology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for LSE
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 72 |
| 2024 | 1 | 272 |
| 2026 | 2 | 249 |
Compare with all 510(k) review times · Search every LSE clearance
Top LSE applicants
| Applicant | Clearances | Latest |
|---|---|---|
| DiaSorin, Inc. | 5 | 2017-01-05 |
| Zeus Scientific, Inc. | 5 | 1998-12-10 |
| Quest Intl., Inc. | 4 | 2009-06-08 |
| Genbio | 4 | 2001-06-11 |
| Whittaker Bioproducts, Inc. | 4 | 1989-10-16 |
21 more applicants have LSE clearances. See the full list in Caduvo.
Most recent LSE clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260221 | Roche Diagnostics | Elecsys EBV EBNA IgG | 2026-10-02 | 249 |
| K260232 | Roche Diagnostics | Elecsys EBV VCA IgG | 2026-10-02 | 249 |
| K233606 | Biokit, S.A. | ADVIA Centaur EBV-VCA IgM | 2024-08-07 | 272 |
| K162961 | DiaSorin, Inc. | LIAISON® VCA IgG and LIAISON® VCA IgG Serum Control Set; LIAISON® EBNA IgG and LIAISON® EBNA IgG Serum Control Set | 2017-01-05 | 73 |
| K162959 | DiaSorin, Inc. | LIAISON® EA IgG and LIAISON® EA IgG Serum Control Set | 2017-01-04 | 72 |
Recalls for LSE devices
7 product recalls in 6 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2025-11-03.
| Year | Recalls |
|---|---|
| 2025 | 1 |
Frequently asked questions
What is FDA product code LSE?
LSE is the FDA product code for epstein-barr virus, other. It is a Class I device, regulated under 21 CFR 866.3235 and reviewed by the Microbiology panel.
What device class is LSE?
Class I, regulation 21 CFR 866.3235. Typical premarket route: 510(k).
How long does a 510(k) take for product code LSE?
Across 58 cleared submissions the average was 176 days from receipt to decision (median 146).
Which companies have the most LSE clearances?
DiaSorin, Inc. (5); Zeus Scientific, Inc. (5); Quest Intl., Inc. (4); Genbio (4); Whittaker Bioproducts, Inc. (4).
Have LSE devices been recalled?
Yes: 7 product recalls across 6 recall events; the most recent began 2025-11-03.
Next steps
- Run an FDA pathway report with predicate devices for product code LSE
- Run a recall and safety report across every LSE manufacturer
- Watch product code LSE for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times